Meticrane
Chemical compound
- C03BA09 (WHO)
- In general: ℞ (Prescription only)
- 6-methylthiochromane-7-sulfonamide 1,1-dioxide
- 1084-65-7
- 4165
- 4021
- I7EKN1924Q
- DTXSID9045346
- Interactive image
- CC1=C(C=C2C(=C1)CCCS2(=O)=O)S(=O)(=O)N
InChI
- InChI=1S/C10H13NO4S2/c1-7-5-8-3-2-4-16(12,13)10(8)6-9(7)17(11,14)15/h5-6H,2-4H2,1H3,(H2,11,14,15)
- Key:FNQQBFNIYODEMB-UHFFFAOYSA-N
Meticrane (INN) is a diuretic.[1]
References
- ^ Ukrainets IV, Bereznyakova NL (April 2012). "Heterocyclic diuretics". Chemistry of Heterocyclic Compounds. 48 (1): 155–65. doi:10.1007/s10593-012-0979-1. S2CID 189843422.
- v
- t
- e
Diuretics (C03)
(and etacrynic acid)
CA inhibitors (at PT) | |
---|---|
Loop (Na-K-Cl at AL) | |
Thiazides (Na-Cl at DCT, Calcium-sparing) | |
Thiazide-likes (primarily DCT) |
ESC blockers | |
---|---|
Aldosterone antagonists |
(DCT and CD)
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e